In rat hepatoma cells the synthetic glucocorticoid dexamethasone causes a 3-fold increase in the activity of the plasma membrane enzyme alkaline phosphodiesterase I (oligonucleat 5'-nucleotidohydrolase, EC 3.1.4.1). The data are consistent with an induction phenomenon mediated by the glucocorticoid receptor involved in tyrosine aminotransferase induction. The effect on alkaline phosphodiesterase I is not a reflection of a general membrane effect of dexamethasone, because the activity of three other enzymes of the plasma membrane is unaffected. On the other hand, nucleoside diphosphatase (nucleoside diphosphate phosphohydrolase acting on ADP) activity is inhibited. Thus, two more enzymes sensitive to glucocorticoids have been identified in a cell line in which these hormones influence only very few gene products. This paper describes enzymatic changes in the plasma membrane of rat hepatoma cells in which glucocorticoids normalize a number of membrane-associated processes that are cons... Glucocorticoids modify several properties of cellular plasma membranes. One of the earliest effects of these hormones in lymphoid cells is an inhibition of hexose, nucleoside, and amino acid uptake (1). Glucocorticoid hormones also decrease hexose uptake by fibroblasts (2) and by adipocytes (3). In rat hepatoma tissue culture (HTC) cells, glucocorticoids promote cell adhesiveness and the reappearance of surface antigens present in normal hepatocytes (4). These hormones also inhibit the release of plasminogen activator (5) and the uptake of aminoisobutyric acid (6, 7), and they decrease the number of cell surface microvilli (8). Such modifications of HTC cell membrane functions have been considered as part of a program of glucocorticoid-induced reversal of the transformed phenotype (8). The biochemical reactions underlying these effects have not been elucidated.
ABSTRACT
In rat hepatoma cells the synthetic glucocorticoid dexamethasone causes a 3-fold increase in the activity of the plasma membrane enzyme alkaline phosphodiesterase I (oligonucleate 5'-nucleotidohydrolase, EC 3.1.4.1). The data are consistent with an induction phenomenon mediated by the glucocorticoid receptor involved in tyrosine aminotransferase induction. The effect on alkaline phosphodiesterase I is not a reflection of a general membrane effect of dexamethasone, because the activity of three other enzymes of the plasma membrane is unaffected. On the other hand, nucleoside diphosphatase (nucleoside diphosphate phosphohydrolase acting on ADP) activity is inhibited. Thus, two more enzymes sensitive to glucocorticoids have been identified in a cell line in which these hormones influence only very few gene products. This paper describes enzymatic changes in the plasma membrane of rat hepatoma cells in which glucocorticoids normalize a number of membrane-associated processes that are considered to be characteristic of transformed cells.
Glucocorticoids modify several properties of cellular plasma membranes. One of the earliest effects of these hormones in lymphoid cells is an inhibition of hexose, nucleoside, and amino acid uptake (1) . Glucocorticoid hormones also decrease hexose uptake by fibroblasts (2) and by adipocytes (3) . In rat hepatoma tissue culture (HTC) cells, glucocorticoids promote cell adhesiveness and the reappearance of surface antigens present in normal hepatocytes (4) . These hormones also inhibit the release of plasminogen activator (5) and the uptake of aminoisobutyric acid (6, 7) , and they decrease the number of cell surface microvilli (8) . Such modifications of HTC cell membrane functions have been considered as part of a program of glucocorticoid-induced reversal of the transformed phenotype (8) . The biochemical reactions underlying these effects have not been elucidated.
Glucocorticoid hormones appear to produce many of their physiological effects through a stimulation of the activity of specific enzymes in target cells, most often as a result of an increase in their rate of synthesis (9) . This prompted us to examine whether enzymes located in the plasma membrane could be under glucocorticoid control, an effect that might be related to one or more of the phenomena described above. This possibility was investigated in HTC cells wherein the interaction of steroids with intracellular receptors and the ensuing induction of tyrosine aminotransferase (L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5) have been extensively studied as a model of glucocorticoid action. (10) . In this system the hormonal response is very specific in that the number of glucocorticoidsensitive gene products is quite limited (11) . Only seven proteins are reproducibly induced, including two unidentified membrane proteins. We show here that, in HTC cells, glucocorticoid hormones specifically increase the activity of alkaline phosphodiesterase I (oligonucleate 5'-nucleotidohydrolase, EC 3.1.4.1), an enzyme localized in the plasma membrane of HTC (ref. 12 ; P. Sauvage and P. Tulkens, personal communication) and normal liver cells (13, 14) .
MATERIALS AND METHODS
Cell Culture. HTC cells, clone 4 from Gordon Tomkins' laboratory, were grown and maintained as described (4) Enzyme Assays. For determination of alkaline phosphodiesterase I, frozen HTC cells were sonicated for 10 sec (Branson Sonifier) in an aqueous solution of Triton X-100 (1 g/liter). Enzyme activity was determined as described by Beaufay et al. (15) by incubating the sample for 10 min at 250C in a mixture containing 0.1 M glycine-NaOH (pH 9.6), 2 mM zinc acetate, and 3 mM p-nitrophenylthymidine 5'-phosphate (from Sigma or Boehringer Mannheim). The reaction rate was constant for at least 20 min and the assay was linear with protein concentration up to 120 ,ug per assay. For determination of tyrosine aminotransferase activity, cells were sonicated as described above in 50 mM potassium phosphate buffer (pH 7.6) containing 5 mM 2-oxoglutarate, 1 mM EDTA, and 0.2 mM pyridoxal phosphate. Enzyme activity was determined according to the method of Diamondstone (16) , as modified by Granner et al. (17) .
Other enzymes were assayed by using cell homogenates (Dounce homogenizer tight pestle) prepared in 0.25 M sucrose/3 mM imidazole-HCI, pH 7.4. Each reaction was conducted in a 1-ml incubation mixture. The alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, EC 2 ,g of oligomycin per ml with incubation for 20 min at 370C and pH 7.4. Nucleoside diphosphatase (nucleoside diphosphate phosphohydrolase acting on ADP) activity was quantitated in a mixture containing 50 mM TrisHCl, 5 mM ADP, and 5 mM CaCl2 incubated for 20 min at 30'C and pH 7.5. In the last two reactions, 1 ml of 15% trichloroacetic acid was added at the end of the incubation time and phosphate was determined by the method of Fiske and Subbarow (19) .
Other Methods. Assays for cell adhesiveness were performed according to Ballard and Tomkins (4) . Cells were centrifuged and resuspended in serum-free medium and their concentration was measured by turbidimetry at 650 nm. The cells were allowed to attach to the bottom of the glass vessel for 2 hr and then were agitated for 3 min at 100 rpm on a Buchler SM rotary shaker and the turbidity of the suspension was again determined. The decrease in optical density, expressed as the percentage change in the optical density caused by attachment, was taken as a measure of cell adhesiveness. Protein was determined by the method of Lowry et al. (20) .
RESULTS
Effect of Dexamethasone on HTC Cell Enzymes. HTC cells were exposed to dexamethasone, a synthetic glucocorticoid, for 48 hr at a concentration (0.1-0.5 uM) that saturates the glucocorticoid receptor and evokes a maximal effect on tyrosine aminotransferase (21) . As shown in Table 1 , this treatment results in a more than 10-fold increase in the activity of this enzyme. The cell protein content was not significantly modified by dexamethasone. We also confirmed that the adhesiveness to glass of this HTC clone is increased by dexamethasone from 18.8% ± 4.6 to 43.0% ± 7.2 (mean + SEM of seven separate experiments). The activities of several enzymes were determined after the same glucocorticoid treatment. We consistently observed a 3-fold increase in the activity of the plasma membrane enzyme alkaline phosphodiesterase I (Table 1) . This effect appears to be specific because no increase occurred for alkaline phosphatase, Mg2+ ATPase, and aminopeptidase (Table 1) . Interestingly, there was a decrease in the activity of nucleoside diphosphatase. These four enzymes are considered to be primarily associated with the plasma membrane in hepatocytes (ref. 22 Fig. 1 . These plots exhibit a thermal transition that is typical of some membrane enzymes (25) . The energies of activation and the transition temperature are essentially the same with and without stimulation of the cells with dexamethasone. Such is also the case for the dependence on pH and zinc concentration (Table 2) .
Finally, we examined whether dexamethasone increased the Vx of the enzyme or its affinity for the substrate. The latter 00C) or to the assay reaction mixture (10 min, 250C) did not influence the activity of this enzyme. Second, in the intact cell, various steroids increased alkaline phosphodiesterase I activity according to their ability to induce the cytosoluble enzyme tyrosine aminotransferase (Table 3) . Of the naturally occurring glucocorticoids, cortisol and corticosterone were the most active. No effect was seen with tetrahydrocorticosterone, an hormonally inactive glucocorticoid metabolite, nor with the sex steroid hormones. Third, a 200-fold (10) or of the partial antagonist deoxycorticosterone (10) inhibited the stimulatory effect of dexamethasone (not shown).
Fourth, we find that HTC cell alkaline phosphodiesterase I activity is increased by concentrations of dexamethasone as low as 2 nM. The dose-response curve (Fig. 2) shows that this process is as sensitive to dexamethasone as is the induction of tyrosine aminotransferase. The half-maximum effect for both is achieved at 15-20 nM dexamethasone, a concentration similar to the equilibrium dissociation constant for the glucocorticoid receptor (10, 21) . This experiment was done in serum-free medium to ensure that the low levels of glucocorticoids present in serum would not shift the dose-response curve. However, the stimulation of alkaline phosphodiesterase I activity also occurs in the presence of serum (Table 1) . Taken together, the data presented in this section suggest that this action of glucocorticoid hormones is mediated by the same receptor as that involved in the induction of tyrosine aminotransferase.
Mechanism of the Glucocorticoid Effect. The stimulation of alkaline phosphodiesterase I activity becomes apparent after a lag period of at least 8 hr (Fig. 3) and is maximal after 48-72 hr, depending on the feeding schedule of the culture. The lag period is consistent with an indirect effect of the hormone, perhaps an induction of new enzyme molecules as is the case for tyrosine aminotransferase. It is also possible that glucocorticoids induce a slowly turning-over factor which in turn enhances the catalytic activity of alkaline phosphodiesterase I. Such a mechanism is thought to operate in the stimulation of alkaline phosphatase activity by glucocorticoids in HeLa cells (27) . However, alkaline phosphodiesterase I activity in mixtures of extracts from control and dexamethasone-treated cells is strictly additive (Fig. 4) . This does not support the idea that dexamethasone promotes the appearance of an activator or inactivates an inhibitor present in control cells.
Upon removal of dexamethasone from HTC cells exposed the phenomenon of increased cell adhesiveness (4), but differ from the rapid induction and deinduction of tyrosine aminotransferase, an enzyme that has a half-life of 2-3 hr. Such kinetic differences are consistent with the different half-lives of these enzymes if stimulation is the result of an increased rate of synthesis. We investigated whether the stimulation of alkaline phosphodiesterase I by dexamethasone required concomitant RNA and protein synthesis. As shown in Fig. 3 , actinomycin D and cycloheximide both prevent the glucocorticoid effect. The induction of tyrosine aminotransferase is also blocked, as expected. (unpublished data). The physiological function of alkaline phosphodiesterase I is unknown. Its external location enables it to interact with the cellular environment and this enzyme responds to glucocorticoids with the same time-course, dose-response, and steroid specificity as does cell adhesiveness (4). It is therefore tempting to speculate that both events are functionally related.
DISCUSSION
Our observations may also provide insight into the mechanism whereby glucocorticoid hormones regulate the expression of specific genes. This is thought to result from an increase in the concentration of specific mRNAs, presumably by a direct effect on transcription. Indeed, dexamethasone increases the activity of tyrosine aminotransferase mRNA in HTC cells (30) . The finding that nucleoside diphosphatase is inhibited by dexamethasone pertains to the question of whether glucocorticoids can repress as well as induce polypeptide synthesis (11) . These hormones certainly inhibit several cell functions. However, in the few instances in which the mechanism has been elucidated, the inhibition results from the stimulation of an inhibitory factor. This is the case for the inhibition by dexamethasone of plasminogen activator activity (31) and of amino acid uptake in HTC cells (8) . If Finally, the possibility of specifically modifying the concentration of membrane enzymes by glucocorticoids could give clues about the functions and biogenesis of the plasma membrane in HTC (35) and normal cells.
